Does ROSUVASTATIN Cause Nasopharyngitis? 526 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 526 reports of Nasopharyngitis have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 1.5% of all adverse event reports for ROSUVASTATIN.
526
Reports of Nasopharyngitis with ROSUVASTATIN
1.5%
of all ROSUVASTATIN reports
3
Deaths
147
Hospitalizations
How Dangerous Is Nasopharyngitis From ROSUVASTATIN?
Of the 526 reports, 3 (0.6%) resulted in death, 147 (27.9%) required hospitalization, and 6 (1.1%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 526 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which ROSUVASTATIN Alternatives Have Lower Nasopharyngitis Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN